Showing results (791-800 of 821) with videos related to
Sort By:
Pageof 83
The European Respiratory Journal|August 12, 2017
Immune-checkpoint inhibitors associated with interstitial lung disease in cancer patientsMyriam Delaunay, Jacques Cadranel, Amélie Lusque, et al.Nature Communications|September 8, 2019
Central nicotine induces browning through hypothalamic κ opioid receptorPatricia Seoane-Collazo, Laura Liñares-Pose, Eva Rial-Pensado, et al.Respiratory Research|January 23, 2025
The fibronectin-targeting PEG-FUD imaging probe shows enhanced uptake during fibrogenesis in experimental lung fibrosisThomas J Harr, Nikesh Gupta, Babita Rahar, et al.Biorxiv : the Preprint Server for Biology|July 14, 2025
Enhancer-driven gene regulatory network of forebrain human development provides insights into autismAlexandre Jourdon, Jessica Mariani, Abhiram Natu, et al.Frontiers in Oncology|June 1, 2023
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogramVittorio Rampinelli, Marco Ferrari, Davide Mattavelli, et al.Italian Journal of Dermatology and Venereology|March 9, 2022
Italian adaptation of EuroGuiDerm guideline on the systemic treatment of chronic plaque psoriasisPaolo Gisondi, Maria C Fargnoli, Paolo Amerio, et al.World Journal of Urology|August 3, 2020
How radical prostatectomy procedures have changed over the last 10 years in Italy: a comparative analysis based on more than 1500 patients participating in the MIRROR-SIU/LUNA and the Pros-IT CNR studyMauro Gacci, Walter Artibani, Pierfrancesco Bassi, et al.Clinical Lung Cancer|January 16, 2026
Patient-Relevant Outcomes From the Phase III MARIPOSA-2 Trial: Amivantamab-Chemotherapy Versus Chemotherapy in EGFR-Mutant Advanced Non-Small-Cell Lung Cancer Following Disease Progression on OsimertinibPascale Tomasini, Oscar Juan-Vidal, Raffaele Califano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 8, 2022
Comprehensive Genome Profiling in Patients With Metastatic Non-Small Cell Lung Cancer: The Precision Medicine Phase II Randomized SAFIR02-Lung/IFCT 1301 TrialFabrice Barlesi, Pascale Tomasini, Maryam Karimi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 6, 2024
Telisotuzumab Vedotin Monotherapy in Patients With Previously Treated c-Met Protein-Overexpressing Advanced Nonsquamous EGFR-Wildtype Non-Small Cell Lung Cancer in the Phase II LUMINOSITY TrialD Ross Camidge, Jair Bar, Hidehito Horinouchi, et al.Pageof 83